157 related articles for article (PubMed ID: 21537998)
1. Effects of benzalkonium chloride on the ocular surface of the rabbit.
Kim JR; Oh TH; Kim HS
Jpn J Ophthalmol; 2011 May; 55(3):283-293. PubMed ID: 21537998
[TBL] [Abstract][Full Text] [Related]
2. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride.
Xiong C; Chen D; Liu J; Liu B; Li N; Zhou Y; Liang X; Ma P; Ye C; Ge J; Wang Z
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1850-6. PubMed ID: 18436819
[TBL] [Abstract][Full Text] [Related]
3. Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions.
Liang H; Brignole-Baudouin F; Riancho L; Baudouin C
Ophthalmic Res; 2012; 48(2):89-101. PubMed ID: 22473057
[TBL] [Abstract][Full Text] [Related]
4. Research on the stability of a rabbit dry eye model induced by topical application of the preservative benzalkonium chloride.
Li C; Song Y; Luan S; Wan P; Li N; Tang J; Han Y; Xiong C; Wang Z
PLoS One; 2012; 7(3):e33688. PubMed ID: 22438984
[TBL] [Abstract][Full Text] [Related]
5. Sodium hyaluronate decreases ocular surface toxicity induced by benzalkonium chloride-preserved latanoprost: an in vivo study.
Yu F; Liu X; Zhong Y; Guo X; Li M; Mao Z; Xiao H; Yang S
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3385-93. PubMed ID: 23620425
[TBL] [Abstract][Full Text] [Related]
6. [Protection effect of sodium hyaluronate on ocular surface toxicity induced by Benzalkonium chloride-preserved brimonidine in rabbits].
Yu FF; Liu X; Zhong YM; Mao Z; Guo XX; Li M; Cao D; Chen XX
Zhonghua Yan Ke Za Zhi; 2013 Nov; 49(11):973-80. PubMed ID: 24512997
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the ocular surface changes following the use of two different prostaglandin F2α analogues containing benzalkonium chloride or polyquad in rabbit eyes.
Lee HJ; Jun RM; Cho MS; Choi KR
Cutan Ocul Toxicol; 2015; 34(3):195-202. PubMed ID: 25265260
[TBL] [Abstract][Full Text] [Related]
8. Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride.
Liang H; Baudouin C; Pauly A; Brignole-Baudouin F
Br J Ophthalmol; 2008 Sep; 92(9):1275-82. PubMed ID: 18723745
[TBL] [Abstract][Full Text] [Related]
9. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
Ammar DA; Noecker RJ; Kahook MY
Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
[TBL] [Abstract][Full Text] [Related]
10. Conjunctiva-associated lymphoid tissue (CALT) reactions to antiglaucoma prostaglandins with or without BAK-preservative in rabbit acute toxicity study.
Liang H; Baudouin C; Labbe A; Riancho L; Brignole-Baudouin F
PLoS One; 2012; 7(3):e33913. PubMed ID: 22442734
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of conjunctival goblet cells after chronic application of topical drops.
Kahook MY; Noecker R
Adv Ther; 2008 Aug; 25(8):743-51. PubMed ID: 18670744
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation.
Pauly A; Roubeix C; Liang H; Brignole-Baudouin F; Baudouin C
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8172-80. PubMed ID: 23150620
[TBL] [Abstract][Full Text] [Related]
13. Reduction of quaternary ammonium-induced ocular surface toxicity by emulsions: an in vivo study in rabbits.
Liang H; Brignole-Baudouin F; Rabinovich-Guilatt L; Mao Z; Riancho L; Faure MO; Warnet JM; Lambert G; Baudouin C
Mol Vis; 2008 Jan; 14():204-16. PubMed ID: 18347566
[TBL] [Abstract][Full Text] [Related]
14. Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study.
Labbé A; Pauly A; Liang H; Brignole-Baudouin F; Martin C; Warnet JM; Baudouin C
J Ocul Pharmacol Ther; 2006 Aug; 22(4):267-78. PubMed ID: 16910868
[TBL] [Abstract][Full Text] [Related]
15. The conjunctival epithelium in dry eye subtypes: effect of preserved and non-preserved topical treatments.
Albietz JM; Bruce AS
Curr Eye Res; 2001 Jan; 22(1):8-18. PubMed ID: 11402374
[TBL] [Abstract][Full Text] [Related]
16. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
Kahook MY; Noecker RJ
Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
[TBL] [Abstract][Full Text] [Related]
17. Phototoxic effects of an operating microscope on the ocular surface and tear film.
Hwang HB; Kim HS
Cornea; 2014 Jan; 33(1):82-90. PubMed ID: 24310622
[TBL] [Abstract][Full Text] [Related]
18. Effects of benzalkonium chloride and cyclosporine applied topically to rabbit conjunctiva: a histomorphometric study.
Faria NVL; Sampaio MOB; Viapiana GN; Seabra NM; Russ HH; Montiani-Ferreira F; Mello PAA
Arq Bras Oftalmol; 2019; 82(4):310-316. PubMed ID: 31038554
[TBL] [Abstract][Full Text] [Related]
19. Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells.
Ammar DA; Noecker RJ; Kahook MY
Adv Ther; 2011 Jun; 28(6):501-10. PubMed ID: 21603985
[TBL] [Abstract][Full Text] [Related]
20. Corneal and conjunctival changes caused by commonly used glaucoma medications.
Noecker RJ; Herrygers LA; Anwaruddin R
Cornea; 2004 Jul; 23(5):490-6. PubMed ID: 15220734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]